Clinical studies recruiting near Bochum

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753 Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Phase 2 · Universitaetsklinikum Knappschaftskrankenhaus Bochum der Ruh · Miltenyi Biomedicine GmbH · NCT04844866 Perturbation-Based Treadmill Training to Prevent Unrecovered Falls in Geriatric Patients
NA · University of Oldenburg · NCT06652828 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Berufsgenossenschaftliches Universitaetsklinikum Bergmannshe · Amgen · NCT07037433 A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advance
Phase 1/Phase 2 · GSK Investigational Site · GlaxoSmithKline · NCT06885034 - IKF/AIO-QUINTIS - Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite Stable / Proficient Misma
Phase 2 · Katholisches Klinikum Bochum gGmbH · Institut für Klinische Krebsforschung IKF GmbH at Krankenhau · NCT06856837 A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD
Phase 1/Phase 2 · Katholisches Klinikum Bochum · Vico Therapeutics B. V. · NCT05822908 A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Phase 2 · Katholisches Klinikum Bochum gGmB · Takeda · NCT07244263 A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorecta
Phase 1 · Katholisches Klinikum Bochum gGmbH - St. Josef-Hospital · Hoffmann-La Roche · NCT04929223 A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced
Phase 1/Phase 2 · St. Josef-Hospital im Katholischen Klinikum Bochum · BioNTech SE · NCT07186842 A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · Augusta-Kranken-Anstalt ( Site 1213) · Merck Sharp & Dohme LLC · NCT06077760 GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of
Phase N/A · Augsuta Krankenanstalt Bochum · Goethe University · NCT02872987 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Boehringer Ingelheim · NCT06531824 Mucous Fistula Refeeding Reduces the Time From Enterostomy Closure to Full Enteral Feeds ("MUC-FIRE" Trial)
NA · University of Leipzig · NCT03469609 Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Phase 3 · Siteworks GmbH - Bochum · Eli Lilly and Company · NCT07353931 A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (
Phase 3 · Investigational Site Number : 2760007 · Sanofi · NCT06290128 A Global Prospective Observational Registry of Patients With Pompe Disease
Phase N/A · Ruhr-Universität Bochum im St. Josef-Hospital · Amicus Therapeutics · NCT06121011 Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.
Phase N/A · Katholisches Klinikum Bochum - St. Joseph-Hospital · icometrix · NCT06280755 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06692738 The EUROSCA Natural History Study
Phase N/A · Department of Neurology, St. Josef Hospital, University Hosp · Ataxia Study Group · NCT02440763 Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochemotherapy in Elderly PCNS
Phase 3 · Universitätsklinikum Knappschaftskrankenhaus Bochum GmbH · University Hospital Freiburg · NCT06830421 A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed Brain Tumors (Gliomas).
Phase 3 · Knappschaftskrankenhaus Bochum GmbH, Neurology Clinic · University Hospital Heidelberg · NCT05331521 A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancre
Phase 3 · Investigative Site DE003 · Incyte Corporation · NCT07522073 LUPUS-BEST - Treat-to-target in Systemic Lupus Erythematosus
NA · Heinrich-Heine University, Duesseldorf · NCT05714930 A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06830720 Establishment of a Tumor Bank for Blood Samples
Phase N/A · Medical University of Vienna · NCT01763125 A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (M
Phase 3 · Augusta-Kranken-Anstalt ( Site 2702) · Merck Sharp & Dohme LLC · NCT07513376 A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson'
Phase 3 · St. Josef-Hospital, Klinik für Neurologie · Hoffmann-La Roche · NCT07174310 AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obst
Phase 3 · Siteworks GmbH Bochum · Novo Nordisk A/S · NCT07571005 A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa
Phase 2/Phase 3 · St. Josef-Hospital Bochum · Bluefin Biomedicine, Inc. · NCT07287644

Look up another city

Look up another condition